Evidence map›Paper›PMID 35032958›Full record

ArticleJournal of hazardous materials2022

Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media.

Chedly Tizaoui, Richard Stanton, Evelina Statkute, Anzelika Rubina, Edward Lester-Card, Anthony Lewis, Peter Holliman, Dave Worsley

Open access · hybridAbstract read
In one paragraph

Article in Journal of hazardous materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Ozone application in different industries: A review of recent developments.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ozone Eliminates SARS-CoV-2 from Difficult-to-Clean Office Supplies and Clinical Equipment.International journal of environmental research and public health · 2022
    Article
  19. Microbial Inactivation: Gaseous or Aqueous Ozonation?Industrial & engineering chemistry research · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chedly TizaouiCollege of Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, United Kingdom. Electronic address: c.tizaoui@swansea.ac.uk.
Richard StantonDivision of Infection & Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, United Kingdom.
Evelina StatkuteDivision of Infection & Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, United Kingdom.
Anzelika RubinaDivision of Infection & Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, United Kingdom.
Edward Lester-CardCollege of Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, United Kingdom.
Anthony LewisCollege of Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, United Kingdom.
Peter HollimanCollege of Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, United Kingdom.
Dave WorsleyCollege of Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, United Kingdom.
Swansea University · GBCardiff University · GB

Funding

Medical Research Council MR/S00971X/1
6 · The paper itself

Abstract

This study evaluated the inactivation of SARS-CoV-2, the virus responsible for COVID-19, by ozone using virus grown in cell culture media either dried on surfaces (plastic, glass, stainless steel, copper, and coupons of ambulance seat and floor) or suspended in liquid. Treatment in liquid reduced SARS-CoV-2 at a rate of 0.92 ± 0.11 log

Indexed as

COVID-19OzoneCell Culture TechniquesHumansSARS-CoV-2Virus InactivationOzoneDisinfectionOzoneSanitisationSARS-CoV-2Virus

Identifiers

PMID35032958
PMCPMC8744407
OpenAlexW4205916644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.